Brown Advisory
Brown Advisory US Flexible Equity Fund
US
Jun 2025 → Sep 2025
Our archive holds 2 letters from this strategy, behind 2 investment theses and positions in 27 companies. Every quote below is copied verbatim from the letter it came from.
2 letters in a year · follow all of Brown Advisory for every strategy.
What it bought and sold
We trimmed Amer Sports (AS) on price strength reducing the weighting in the Consumer Discretionary sector.
In Information Technology, we added to Analog Devices (ADI) and Workday (WDAY) and trimmed Apple (AAPL), Autodesk (ADSK) and Marvell Technology.
In Information Technology, we added to Analog Devices (ADI) and Workday (WDAY) and trimmed Apple (AAPL), Autodesk (ADSK) and Marvell Technology.
We also trimmed Ferguson Enterprises (FERG) and GE Aerospace (GE).
We added to Align Technology (ALGN) and Elevance Health (ELV) in Health Care and trimmed Illumina (ILMN).
We trimmed KKR & Co. (KKR) and added to Charles Schwab (SCHW) and Fiserv (FI) in Financials.
In Information Technology, we added to Analog Devices (ADI) and Workday (WDAY) and trimmed Apple (AAPL), Autodesk (ADSK) and Marvell Technology.
In Information Technology, we added to Analog Devices (ADI) and Workday (WDAY) and trimmed Apple (AAPL), Autodesk (ADSK) and Marvell Technology.
We added to Align Technology (ALGN) and Elevance Health (ELV) in Health Care and trimmed Illumina (ILMN).
We trimmed KKR & Co. (KKR) and added to Charles Schwab (SCHW) and Fiserv (FI) in Financials.
We also trimmed Ferguson Enterprises (FERG) and GE Aerospace (GE).
We added to Align Technology (ALGN) and Elevance Health (ELV) in Health Care and trimmed Illumina (ILMN).
The Consumer Staples sector fell the most in the quarter, but the weighting was relatively unchanged since we added to Mondelez International (MDLZ).
We trimmed KKR & Co. (KKR) and added to Charles Schwab (SCHW) and Fiserv (FI) in Financials.
Also held
Its investment theses
- Charles SchwabJun 2025Charles Schwab is a well-regarded financial services company that, after facing significant challenges related to the 2023 regional banking crisis, has shown signs of recovery and improvement in its balance sheet, positioning itself to return to its original growth model.
- UnitedHealthJun 2025UnitedHealth is facing short-term challenges due to internal execution issues and mispricing but remains a strong long-term investment prospect given its discounted valuation and the expected corrections through annual repricing cycles.